0001209191-15-076490.txt : 20151022 0001209191-15-076490.hdr.sgml : 20151022 20151022182439 ACCESSION NUMBER: 0001209191-15-076490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151020 FILED AS OF DATE: 20151022 DATE AS OF CHANGE: 20151022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kaye Edward M. MD CENTRAL INDEX KEY: 0001522780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 151171306 MAIL ADDRESS: STREET 1: 3450 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98011 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-10-20 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001522780 Kaye Edward M. MD 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 SVP Interim CEO & CMO Common Stock 2015-10-20 4 F 0 3001 26.74 D 106893 D Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock. Includes shares purchased under the Company's employee stock purchase plan prior to the reported transaction. /s/ David Tyronne Howton 2015-10-22